Andrew Gray Urquhart, MD
Clinical Professor of Orthopaedic Surgery
Section Head, Adult Joint Surgery, Orthopaedic Surgery
Service Chief, Adult Joint Surgery, Orthopaedic Surgery

Available to mentor

Andrew Gray Urquhart, MD
Clinical Professor
  • About
  • Qualifications
  • Research Overview
  • Recent Publications
  • About

    Dr. Andrew Urquhart is a Clinical Professor of Orthopaedics at the University of Michigan Health System. He is the chief of the division of hip and knee reconstruction. Dr. Urquhart is a true local. He grew up on a farm between Dexter and Chelsea. He attended Albion College and went on to medical school at the University of Michigan. He completed his general surgery internship as well as his Orthopaedic residency here at the University as well. Following the completion of his Orthopaedic training he completed a one year fellowship in hip and knee reconstruction at the Scripps Green Hospital in La Jolla California. After the completion of his fellowship he joined private practice in Northwest Ohio and was active in the education of orthopaedic residents at the Medical College of Ohio in Toledo. He returned to the University of Michigan in January of 2001 to take over the division of hip and knee reconstruction from his mentor Dr. Larry Matthews. Since returning to the University, Andy has focused his research and teaching efforts on improving reliability and reproducibility of hip and knee reconstruction.

    Dr. Urquhart has received numerous teaching awards for his efforts at educating the future Orthopaedic surgeons in improving their ability to reliably provide a good implant to their patients. His research interest has mirrored this, exploring many areas including computer assisted surgery, volume associated surgical outcomes and digital planning to evaluate and improve inter- and intra- surgeon variability. Through these efforts Andy has focused his efforts on consistently improving outcomes for patients. He is an active member of his specialty societies. He has served as membership chairman at both the state and national level. He is also a National Orthopaedic Oral Board Examiner. Through these activities he has attempted to “raise the bar” of all practicing Orthopaedic surgeons.

    Qualifications
    • MD
      University of Michigan Medical School, Ann Arbor, 1991
    • BA
      Albion College, Albion, 1987
    Research Overview

    - Prosthetic positioning
    - Bone - implant interfaces

    Recent Publications See All Publications
    • Presentation
      Modern total hip replacement, what is hip and what is hype?
      Urquhart AG. 2024 Jan 25;
    • Presentation
      My aching Knee, best home treatments, when to see a surgeon and what not to inject into your knee.
      Urquhart AG. 2024 Jan 25;
    • Journal Article
      Tibial Post Fracture After Total Knee Arthroplasty: Ultrasound as a Viable Diagnostic Tool: A Case Report.
      Michaels R, Muscatelli S, McHugh M, Lewno A, Urquhart A. JBJS Case Connect, 2022 Oct 1; 12 (4): DOI:10.2106/JBJS.CC.22.00461
      PMID: 36732050
    • Additional Scholarship
      "About Michigan Medicine" Blog Article-Reducing Opioids Prescribed After Total Knee and Hip Arthroplasty Can Be Beneficial for Patients and Doctors
      Goodwin V, Dailey EA, Tollemar V, Urquhart AG, Hallstrom BR, Hu H-M, Waljee J, Bicket M, Brummett C. 2022 Dec 13;
    • Journal Article
      Prosthetic Joint Infection Due to Mycobacterium senegalense After Exposure to Zebu Cattle: A Case Report.
      Jameson AP, Barker SM, Urquhart AG, Pack B. JBJS Case Connect, 2022 Jul 1; 12 (3): DOI:10.2106/JBJS.CC.22.00333
      PMID: 36099360
    • Presentation
      2022 MARCQI Individual Surgeon Reports
      Urquhart AG. 2022 Jun 1;
    • Journal Article
      New persistent opioid use after surgery in patients with a history of remote opioid use.
      Agarwal S, Shah A, Gunaseelan V, Sulich C, McAfee J, Urquhart AG, As-Sanie S, Lin J, Waljee JF, Brummett CM. Surgery, 2022 Jun; 171 (6): 1635 - 1641. DOI:10.1016/j.surg.2021.11.008
      PMID: 34895768
    • Journal Article
      Soluble CD13 induces inflammatory arthritis by activating the bradykinin receptor B1.
      Tsou P-S, Lu C, Gurrea-Rubio M, Muraoka S, Campbell PL, Wu Q, Model EN, Lind ME, Vichaikul S, Mattichak MN, Brodie WD, Hervoso JL, Ory S, Amarista CI, Pervez R, Junginger L, Ali M, Hodish G, O'Mara MM, Ruth JH, Robida AM, Alt AJ, Zhang C, Urquhart AG, Lawton JN, Chung KC, Maerz T, Saunders TL, Groppi VE, Fox DA, Amin MA. J Clin Invest, 2022 Jun 1; 132 (11): DOI:10.1172/JCI151827
      PMID: 35439173